These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Haemophilus influenzae type b vaccines. Howard AJ Br J Hosp Med; 1992 Jun 17-30; 48(1):44-6. PubMed ID: 1504687 [TBL] [Abstract][Full Text] [Related]
26. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b. Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825 [TBL] [Abstract][Full Text] [Related]
27. [When should vaccination against Haemophilus influenzae type b take place?]. Stickl HA Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108 [No Abstract] [Full Text] [Related]
28. [Polysaccharide vaccines against Haemophilus influenzae type B]. WysokiĆska T; Janaszek W Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141 [TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology and evolution of Haemophilus influenzae. Wen S; Feng D; Chen D; Yang L; Xu Z Infect Genet Evol; 2020 Jun; 80():104205. PubMed ID: 31981610 [TBL] [Abstract][Full Text] [Related]
30. Haemophilus b polysaccharide vaccine: need for continuing assessment. Murphy TV Pediatr Infect Dis J; 1987 Aug; 6(8):701-3. PubMed ID: 3313231 [No Abstract] [Full Text] [Related]
31. H influenzae in the post-vaccination era. Peltola H Lancet; 1993 Apr; 341(8849):864-5. PubMed ID: 8096567 [No Abstract] [Full Text] [Related]
32. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Kyd JM; Cripps AW; Novotny LA; Bakaletz LO Infect Immun; 2003 Aug; 71(8):4691-9. PubMed ID: 12874350 [TBL] [Abstract][Full Text] [Related]
33. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer. Weisman SJ; Cates KL; Allegretta GJ; Quinn JJ; Altman AJ J Pediatr; 1987 Nov; 111(5):727-9. PubMed ID: 3499501 [No Abstract] [Full Text] [Related]
34. Failures after immunization with Haemophilus influenzae type b vaccines--1991-1995. Scheifele D; Gold R; Marchessault V; Duclos P Can Commun Dis Rep; 1996 Feb; 22(3):17-20, 23. PubMed ID: 8822260 [No Abstract] [Full Text] [Related]
37. Haemophilus influenzae type b vaccine efficacy in the United States. Gilsdorf JR Pediatr Infect Dis J; 1988 Mar; 7(3):147-8. PubMed ID: 3258658 [No Abstract] [Full Text] [Related]
38. Molecular epidemiology of Haemophilus influenzae type b in the Gambia. Bijlmer HA; van Alphen L; Geelen-van den Broek L; Greenwood BM; Valkenburg HA; Dankert J J Clin Microbiol; 1992 Feb; 30(2):386-90. PubMed ID: 1537907 [TBL] [Abstract][Full Text] [Related]
39. Haemophilus influenzae type b prevention. N Y State J Med; 1989 Jul; 89(7):430-1. PubMed ID: 2788257 [No Abstract] [Full Text] [Related]
40. Progress in Haemophilus type b polysaccharide vaccine use in the United States. Cochi SL; O'Mara D; Preblud SR Pediatrics; 1988 Jan; 81(1):166-8. PubMed ID: 3257297 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]